These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 26918424)

  • 1. Effect of systemic transplantation of bone marrow-derived mesenchymal stem cells on neuropathology markers in APP/PS1 Alzheimer mice.
    Naaldijk Y; Jäger C; Fabian C; Leovsky C; Blüher A; Rudolph L; Hinze A; Stolzing A
    Neuropathol Appl Neurobiol; 2017 Jun; 43(4):299-314. PubMed ID: 26918424
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pyroglutamate Abeta pathology in APP/PS1KI mice, sporadic and familial Alzheimer's disease cases.
    Wirths O; Bethge T; Marcello A; Harmeier A; Jawhar S; Lucassen PJ; Multhaup G; Brody DL; Esparza T; Ingelsson M; Kalimo H; Lannfelt L; Bayer TA
    J Neural Transm (Vienna); 2010 Jan; 117(1):85-96. PubMed ID: 19823761
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Early-life stress lastingly alters the neuroinflammatory response to amyloid pathology in an Alzheimer's disease mouse model.
    Hoeijmakers L; Ruigrok SR; Amelianchik A; Ivan D; van Dam AM; Lucassen PJ; Korosi A
    Brain Behav Immun; 2017 Jul; 63():160-175. PubMed ID: 28027926
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transplantation of Mesenchymal Stem Cells Improves Amyloid-β Pathology by Modifying Microglial Function and Suppressing Oxidative Stress.
    Yokokawa K; Iwahara N; Hisahara S; Emoto MC; Saito T; Suzuki H; Manabe T; Matsumura A; Matsushita T; Suzuki S; Kawamata J; Sato-Akaba H; Fujii HG; Shimohama S
    J Alzheimers Dis; 2019; 72(3):867-884. PubMed ID: 31640102
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Distinct Effects of the Hippocampal Transplantation of Neural and Mesenchymal Stem Cells in a Transgenic Model of Alzheimer's Disease.
    Campos HC; Ribeiro DE; Hashiguchi D; Hukuda DY; Gimenes C; Romariz SAA; Ye Q; Tang Y; Ulrich H; Longo BM
    Stem Cell Rev Rep; 2022 Feb; 18(2):781-791. PubMed ID: 34997526
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effect of focal brain injury on beta-amyloid plaque deposition, inflammation and synapses in the APP/PS1 mouse model of Alzheimer's disease.
    Collins JM; King AE; Woodhouse A; Kirkcaldie MT; Vickers JC
    Exp Neurol; 2015 May; 267():219-29. PubMed ID: 25747037
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intranasal delivery of mesenchymal stem cell secretome repairs the brain of Alzheimer's mice.
    Santamaria G; Brandi E; Vitola P; Grandi F; Ferrara G; Pischiutta F; Vegliante G; Zanier ER; Re F; Uccelli A; Forloni G; de Rosbo NK; Balducci C
    Cell Death Differ; 2021 Jan; 28(1):203-218. PubMed ID: 32704089
    [TBL] [Abstract][Full Text] [Related]  

  • 8. IFN-γ Production by amyloid β-specific Th1 cells promotes microglial activation and increases plaque burden in a mouse model of Alzheimer's disease.
    Browne TC; McQuillan K; McManus RM; O'Reilly JA; Mills KH; Lynch MA
    J Immunol; 2013 Mar; 190(5):2241-51. PubMed ID: 23365075
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intracerebral transplantation of bone marrow-derived mesenchymal stem cells reduces amyloid-beta deposition and rescues memory deficits in Alzheimer's disease mice by modulation of immune responses.
    Lee JK; Jin HK; Endo S; Schuchman EH; Carter JE; Bae JS
    Stem Cells; 2010 Feb; 28(2):329-43. PubMed ID: 20014009
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intracerebral transplantation of adipose-derived mesenchymal stem cells alternatively activates microglia and ameliorates neuropathological deficits in Alzheimer's disease mice.
    Ma T; Gong K; Ao Q; Yan Y; Song B; Huang H; Zhang X; Gong Y
    Cell Transplant; 2013; 22 Suppl 1():S113-26. PubMed ID: 24070198
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Arginase 1+ microglia reduce Aβ plaque deposition during IL-1β-dependent neuroinflammation.
    Cherry JD; Olschowka JA; O'Banion MK
    J Neuroinflammation; 2015 Nov; 12():203. PubMed ID: 26538310
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Amniotic Mesenchymal Stem Cells Decrease Aβ Deposition and Improve Memory in APP/PS1 Transgenic Mice.
    Zheng XY; Wan QQ; Zheng CY; Zhou HL; Dong XY; Deng QS; Yao H; Fu Q; Gao M; Yan ZJ; Wang SS; You Y; Lv J; Wang XY; Chen KE; Zhang MY; Xu RX
    Neurochem Res; 2017 Aug; 42(8):2191-2207. PubMed ID: 28397068
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human umbilical cord blood-derived mesenchymal stem cells improve neuropathology and cognitive impairment in an Alzheimer's disease mouse model through modulation of neuroinflammation.
    Lee HJ; Lee JK; Lee H; Carter JE; Chang JW; Oh W; Yang YS; Suh JG; Lee BH; Jin HK; Bae JS
    Neurobiol Aging; 2012 Mar; 33(3):588-602. PubMed ID: 20471717
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cytokine-producing microglia have an altered beta-amyloid load in aged APP/PS1 Tg mice.
    Babcock AA; Ilkjær L; Clausen BH; Villadsen B; Dissing-Olesen L; Bendixen AT; Lyck L; Lambertsen KL; Finsen B
    Brain Behav Immun; 2015 Aug; 48():86-101. PubMed ID: 25774009
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interferon-gamma and tumor necrosis factor-alpha regulate amyloid-beta plaque deposition and beta-secretase expression in Swedish mutant APP transgenic mice.
    Yamamoto M; Kiyota T; Horiba M; Buescher JL; Walsh SM; Gendelman HE; Ikezu T
    Am J Pathol; 2007 Feb; 170(2):680-92. PubMed ID: 17255335
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Wharton's Jelly-derived mesenchymal stem cells alleviate memory deficits and reduce amyloid-β deposition in an APP/PS1 transgenic mouse model.
    Xie ZH; Liu Z; Zhang XR; Yang H; Wei LF; Wang Y; Xu SL; Sun L; Lai C; Bi JZ; Wang XY
    Clin Exp Med; 2016 Feb; 16(1):89-98. PubMed ID: 26188488
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neuropathology of mice carrying mutant APP(swe) and/or PS1(M146L) transgenes: alterations in the p75(NTR) cholinergic basal forebrain septohippocampal pathway.
    Jaffar S; Counts SE; Ma SY; Dadko E; Gordon MN; Morgan D; Mufson EJ
    Exp Neurol; 2001 Aug; 170(2):227-43. PubMed ID: 11476589
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CXCR3 promotes plaque formation and behavioral deficits in an Alzheimer's disease model.
    Krauthausen M; Kummer MP; Zimmermann J; Reyes-Irisarri E; Terwel D; Bulic B; Heneka MT; Müller M
    J Clin Invest; 2015 Jan; 125(1):365-78. PubMed ID: 25500888
    [TBL] [Abstract][Full Text] [Related]  

  • 19. EGb761 improves cognitive function and regulates inflammatory responses in the APP/PS1 mouse.
    Wan W; Zhang C; Danielsen M; Li Q; Chen W; Chan Y; Li Y
    Exp Gerontol; 2016 Aug; 81():92-100. PubMed ID: 27220811
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Distribution pattern following systemic mesenchymal stem cell injection depends on the age of the recipient and neuronal health.
    Fabian C; Naaldijk Y; Leovsky C; Johnson AA; Rudolph L; Jaeger C; Arnold K; Stolzing A
    Stem Cell Res Ther; 2017 Apr; 8(1):85. PubMed ID: 28420415
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.